Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Xiang-Zhong Zhang"'
Autor:
Jie Deng, Li Chen, Cui‐Cui Liu, Meng Liu, Guo‐Qing Guo, Jia‐You Wei, Jian‐Bo Zhang, Hai‐Ting Fan, Zi‐Kun Zheng, Pu Yan, Xiang‐Zhong Zhang, Feng Zhou, Sui‐Xiang Huang, Ji‐Feng Zhang, Ting Xu, Jing‐Dun Xie, Wen‐Jun Xin
Publikováno v:
Advanced Science, Vol 11, Iss 34, Pp n/a-n/a (2024)
Abstract Clinically, chronic pain and depression often coexist in multiple diseases and reciprocally reinforce each other, which greatly escalates the difficulty of treatment. The neural circuit mechanism underlying the chronic pain/depression comorb
Externí odkaz:
https://doaj.org/article/02d7e81f8a0b43f588c5c2e513c37f84
Autor:
Zi-Jie Long, Jun-Dan Wang, Sheng-Xiang Qiu, Yi Zhang, Si-Jin Wu, Xin-Xing Lei, Ze-Wei Huang, Jia-Jie Chen, Yong-Liang Yang, Xiang-Zhong Zhang, Quentin Liu
Publikováno v:
Pharmacological Research, Vol 197, Iss , Pp 106973- (2023)
Immunogenic cell death (ICD), one of cell-death types through release of damage-associated molecular patterns from dying tumor cells, activates tumor-specific immune response and elicits anti-tumor immunity by traditional radiotherapy and chemotherap
Externí odkaz:
https://doaj.org/article/8e009f61426c4872a5c9d1fe29106570
Autor:
Meng Liu, Su-Bo Zhang, Yu-Xuan Luo, Yan-Ling Yang, Xiang-Zhong Zhang, Bo Li, Yan Meng, Yuan-Jie Chen, Rui-Xian Guo, Yuan-Chang Xiong, Wen-Jun Xin, Dai Li
Publikováno v:
Journal of Neuroinflammation, Vol 17, Iss 1, Pp 1-12 (2020)
Abstract Background The major dose-limiting toxicity of paclitaxel, one of the most commonly used drugs to treat solid tumor, is painful neuropathy. However, the molecular mechanisms underlying paclitaxel-induced painful neuropathy are largely unclar
Externí odkaz:
https://doaj.org/article/f2b86f125c4347bb9a3587344951ac27
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-5 (2019)
Abstract Background After allogeneic haematopoietic stem cell transplantation (allo-HSCT), Hepatitis B virus reactivation (HBVr) can be observed in patients with previous resolved Hepatitis B virus (HBV) infections. Nephrotic syndrome (NS) is the mai
Externí odkaz:
https://doaj.org/article/668aaf754d604540b41e9966b26507e4
Autor:
Bing Long, Le-Xun Wang, Fei-Meng Zheng, Shu-Ping Lai, Duo-Rong Xu, Yuan Hu, Dong-Jun Lin, Xiang-Zhong Zhang, Lin Dong, Zi-Jie Long, Xiu-Zhen Tong, Quentin Liu
Publikováno v:
Cellular Physiology and Biochemistry, Vol 38, Iss 4, Pp 1288-1302 (2016)
Background/Aims: Resistance of leukemia stem cells (LSCs) to chemotherapy in patients with acute myeloid leukemia (AML) causes relapse of disease. Hedgehog (Hh) signaling plays a critical role in the maintenance and differentiation of cancer stem cel
Externí odkaz:
https://doaj.org/article/fa055f22657a4da0836f644889f3f154
Publikováno v:
Proceedings of the International Field Exploration and Development Conference 2021 ISBN: 9789811921483
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1388d5ae5791f7803c65aeddfdca603
https://doi.org/10.1007/978-981-19-2149-0_52
https://doi.org/10.1007/978-981-19-2149-0_52
Publikováno v:
Clinical Laboratory; 2018, Vol. 64 Issue 11/12, p1939-1942, 4p
Autor:
Yang Gao, Wang Xiaoyan, Hao-Wen Xiao, Jian-Yu Weng, Hai-Jia Chen, Xin Du, Jing-Ren Lin, Yang Xiao, Ge Xiaohu, Danian Nie, Dongjun Lin, Huo Tan, Duorong Xu, Hongbo Li, Zujun Jiang, Li Li, Yan Pang, Zenghui Liu, Hang Zhang, Qifa Liu, Xiang-Zhong Zhang
Publikováno v:
Stem Cells Translational Medicine. 6:1569-1575
We conducted a phase II, noncomparative, multicenter study to assess the efficacy and safety of allogeneic bone marrow-derived mesenchymal stromal cells (BM-MSCs) expanded in vitro for patients with aplastic anemia (AA) refractory to immunosuppressiv
Autor:
Xiang-Zhong Zhang (AUTHOR), Ai-Hua Yin (AUTHOR), Dong-Jun Lin (AUTHOR), Xiao-Yu Zhu (AUTHOR), Qian Ding (AUTHOR), Chun-Huai Wang (AUTHOR), Yun-Xian Chen (AUTHOR)
Publikováno v:
Journal of Biomedicine & Biotechnology. 2012, Vol. 2012, p1-8. 8p.
Autor:
Ting-Rong Liu, Xiang-Zhong Zhang, Yi-Chuan Xu, Xiangfu Liu, Rui-Fang Fan, Ying Lu, Ling-Ling Liu
Publikováno v:
Biomedicine & Pharmacotherapy. 84:1551-1557
Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, has been demonstrated to exert antitumor activity in a variety of cancer cells. The underlying mechanism involves inhibition of cell cycle progression and induction of apoptosis. Besides, cel